2017 asc 606, 2017 asc 606 conference, 2017 asc 606 cpe, 2017 asc 606 san jose, 2017 asc 606 santa clara, 2017 asc 606 seminar, 2017 revenue recognition, 2017 revenue recognition seminar, 2017 revenue recognition training asc 606, accounting for biotech 2017, accounting for medical devices 2017, accounting for pharmaceuticals 2017, asc 606 2017, asc 606 cpe, asc 606 training, asc transition revenue recognition, life science accounting 2017, life science accounting conference, life science accounting conference 2017, life science cpe, life science cpe 2017, revenue recognition, revenue recognition transition 2017, san francisco revenue recognition, san jose cpe revenue recognition training
Life Science Accounting Update 2017
SAN JOSE
From technical accounting and revenue recognition new rules to cybersecurity and fraud, this conference will address the latest developments in key areas. You’ll hear from experts at the Big Four and regional firms.
LEARNING OBJECTIVES:
- Understand the latest accounting changes in key areas
- Recognize the timelines and key factors affecting the life science industry
- Begin to assess the effects of these standards on your company or clients
REGISTRATION INFORMATION:
Cost $995
We will email you a 25% off discount code for the hotel after registration
You can also register by phone 610 789-3110
or Email questions or to be invoiced to: mtarman@acslive.com
| Agenda: DAY 1 | ||
|---|---|---|
| 8:00 | 8:45 | Continental Breakfast and Registration |
| 8:45 | 10:15 | Accounting for Leases Overview of New Rules Identifying a Lease Contract Components Lease Classification Recognition and Measurement Ongoing Requirements Practical Expedients Examples |
| 10:15 | 10:30 | Break |
| 10:30 | 12:00 | Gross to Net (GTN) Understanding the Complexities Internal and External Challenges Elements leading to GTN model creation Industry examples |
| 12:00 | 1:00 | Lunch |
| 1:00 | 2:30 | Revenue Recognition: ASC 606 Implementation Issues and Examples Working through the five step model Implementation issues and lessons learned in the life science industry Identify the contract Identify performance obligations Determine the transaction price Allocate the transaction price When to recognize revenue |
| 2:30 | 2:40 | Break |
| 2:40 | 3:40 | New Collaborative Arrangements Guidance Old rules, new proposal Key changes in the works Effective date for new guidance |
| 3:40 | 4:10 | Introductions |
| 4:10 | 4:15 | Break |
| 4:15 | 5:30 | Accounting for International Operations Considerations when going abroad Resources for U.S. businesses including transactional services Letter of credit and trade credit insurance Foreign law compliance Tax structures |
| Agenda: DAY 2 | ||
|---|---|---|
| 8:15 | 8:45 | Continental Breakfast |
| 8:45 | 10:00 | SEC Update Comment letter themes MD&A Update Changing regulatory environment Non-GAAP measures ICFR Material weaknesses Cybersecurity disclosures |
| 10:00 | 10:10 | Break |
| 10:10 | 11:20 | Tax Update R&D Tax Credits Tax Accounting Methods Orphan Drug Credit |
| 11:20 | 12:30 | Accounting for Clinical Trial/R&D Accruals Debt & Equity capital Development stage reporting Determining accrual date |
| 12:30 | 1:30 | Lunch |
| 1:30 | 2:40 | Legal Update Latest Hot Buttons Creative Financing Industry Trends |
| 2:40 | 2:55 | Break |
| 2:55 | 4:20 | Fraud in Life Science Recent Trends Cases and examples Cybersecurity |
| Conference Series Speakers Include: |
|---|
| Michelle Marseglia Deloitte & Touche, Managing Director |
| John McKenna Cooley, Partner |
| Carolyn Selig Deloitte & Touche, Audit Senior Manager |
| Dan Lujan Ernst & Young, Senior Manager |
| Adam Barrow Ernst & Young, Senior Manager |
| Jeny Ciszewski Deloitte & Touche, Partner |
| Eric Berg Effectus Group, Director |
| Angela Rusakova Deloitte & Touche, Partner |
| Mark Strassler Deloitte & Touche, Managing Director |
| Lindsey Piziali PwC, Partner |
| Gary Sardo PwC, Director |
| Kevin Dueck Deloitte & Touche, Partner |